Headquarters
LEVEL 9, SUITE 901, 109, PITT STREET, SYDNEY 2000, AU
SYDNEY, AU
ACTINOGEN MEDICAL LIMITED
From the company
Actinogen Medical Ltd (ACN 086 778 476) is an ASX-listed (code ACW) clinical-stage company developing Xanamem® (emestedastat), an oral therapeutic that controls levels of the stress hormone cortisol in the brain by inhibiting the 11β-HSD1 enzyme. It is developing Xanamem for Alzheimer's disease, Major Depressive Disorder, and other neurological conditions, and has conducted multiple clinical trials including a Phase 2b/3 Alzheimer's disease trial.
Products & services offered
Capabilities 3
Facilities
Send your requirements
Quantities, certifications, and timing.